Dolby Laboratories, Inc. reported $1.35B of revenue over the trailing twelve months, +0.55% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $1.35B (to Q3 2026). Net income: $226M, trailing twelve months to Q3 2026. Free cash flow: $393M, trailing twelve months to Q3 2026. Operating margin: 17%, trailing twelve months to Q3 2026.

DLBDolby Laboratories, Inc.

Industrials

$62.88-6.2% 1Y

$62.88

$48.5152 weeks$68.66

DLB as reported

Dolby Laboratories, Inc. reported $1.35B of revenue over the trailing twelve months, +0.55% on the year before. 10 reported series are charted on this page, each one as filed.

$1.35B

Revenue, trailing twelve months · to Q3 2026 · +0.55% against the twelve months before

Net income: $226M
Net income · −14% year on year · trailing twelve months to Q3 2026
Free cash flow: $393M
Free cash flow · −10% year on year · trailing twelve months to Q3 2026
Operating margin: 17%
Operating margin · trailing twelve months to Q3 2026

Details›

Every series Ryufin has for DLB, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$1.35B	+0.55%	Q3 2026
Net income	$226M	−14%	Q3 2026
EPS	$2.35	−14%	Q3 2026
Gross margin	88%	n/a	Q3 2026
Operating margin	17%	n/a	Q3 2026
Net margin	16%	n/a	Q3 2026
ROE	9.3%	n/a	Q3 2026
ROA	7.5%	n/a	Q3 2026
Free cash flow	$393M	−10%	Q3 2026
P/E	26.8	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.